- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
December 15, 2021
On December 15, the COVID Advocates Advisory Board (CAAB) and AVAC held a webinar about the Omicron variant featuring Salim Abdool Karim, director of the Centre for the AIDS Program of Research in South Africa (CAPRISA). Karim shared the latest updates and what questions are being pursued about Omicron, vaccines and any potential connections to HIV.
For background, read a commentary Karim co-authored with Quarraisha Abdool Karim in The Lancet, Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.